• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房中的氧疗。

Oxygen therapy in the intensive care unit.

作者信息

Wang Ping, Huang Qixin, Liu Bin, Xu Qiangjun, Li Xingsong, Feng Guidong, Liu Yiming

机构信息

Department of Emergency, ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.

Department of Emergency, The Second People's Hospital of Qingyuan City, Qingyuan, Guangdong Province, China.

出版信息

Med Gas Res. 2025 Dec 1;15(4):478-487. doi: 10.4103/mgr.MEDGASRES-D-24-00143. Epub 2025 Apr 29.

DOI:10.4103/mgr.MEDGASRES-D-24-00143
PMID:40300883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12124703/
Abstract

Oxygen therapy is a crucial treatment method for maintaining vital signs in patients in the intensive care unit. However, several controversial issues have emerged regarding its clinical application. This article analyzes current research trends in oxygen therapy in the intensive care unit and provides guidance and recommendations. Relevant literature was retrieved from the Web of Science Core Collection, and keyword co-occurrence and highly cited literature hotspot analyses were conducted using VOSviewer 1.6.19 software. The key topics related to oxygen therapy in the intensive care unit primarily focus on four areas: oxygen therapy and mechanical ventilation in the intensive care unit, extracorporeal membrane oxygenation therapy for coronavirus disease 2019 and its role in reducing mortality, research on hypoxia and oxygen saturation monitoring, and oxygen inhalation therapy in the intensive care unit. The analysis of highly cited literature indicates that the main research hotspots regarding oxygen therapy used in the intensive care unit focus primarily on conservative oxygen therapy, high-flow nasal oxygen therapy, comparisons of high- and low-oxygenation strategies, and research on hyperbaric oxygen therapy. First, the potential of conservative oxygen therapy to reduce mortality rates in the intensive care unit has attracted considerable attention; however, further clinical studies are needed to validate its optimal parameters and suitable patient populations. Second, high-flow nasal oxygen therapy has been shown to be effective in alleviating respiratory distress and reducing the need for intubation. This therapy can deliver oxygen flows of up to 60 L/min, effectively improving respiratory distress and decreasing intubation demands. In patients subjected to high-risk extubation, the combination of high-flow nasal oxygen therapy and noninvasive ventilation significantly lowers the rate of reintubation, making the combined approach one of the best strategies to prevent respiratory failure after extubation in the intensive care unit. Third, there are differences between lower and higher oxygenation strategies regarding their effects on patient mortality, long-term outcomes, and clinician preferences; however, there is currently no clear evidence indicating which strategy is superior. Clinicians' preferences regarding various oxygenation targets may impact the design of future studies. Finally, hyperbaric oxygen therapy is recognized as an effective supportive treatment for various critical conditions and has significant application value in acute severe traumatic brain injury, cerebral resuscitation, and cardiopulmonary resuscitation. Currently, researchers are continually exploring the latest oxygen therapies in the intensive care unit. Several randomized controlled clinical trials investigating automated oxygen control, novel high-flow nasal oxygen therapy, and combined oxygen therapy are underway. The results of these trials should be closely observed. Overall, this article provides a systematic review and valuable reference for the scientific and rational application of oxygen therapy in the intensive care unit. Future research should focus on verifying the optimal parameters of conservative oxygen therapy, assessing oxygen needs in different patient populations, evaluating the long-term effects of oxygen treatment, and developing novel oxygen therapy technologies and devices.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d42/12124703/40a70218f7cc/MGR-15-478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d42/12124703/526c42c1e9ce/MGR-15-478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d42/12124703/40a70218f7cc/MGR-15-478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d42/12124703/526c42c1e9ce/MGR-15-478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d42/12124703/40a70218f7cc/MGR-15-478-g002.jpg
摘要

氧疗是重症监护病房患者维持生命体征的关键治疗方法。然而,其临床应用出现了几个有争议的问题。本文分析了重症监护病房氧疗的当前研究趋势,并提供指导和建议。从科学引文索引核心合集中检索相关文献,并使用VOSviewer 1.6.19软件进行关键词共现和高被引文献热点分析。与重症监护病房氧疗相关的关键主题主要集中在四个方面:重症监护病房的氧疗与机械通气、2019冠状病毒病的体外膜肺氧合治疗及其在降低死亡率中的作用、缺氧和血氧饱和度监测研究、重症监护病房的吸氧治疗。高被引文献分析表明,重症监护病房使用的氧疗主要研究热点主要集中在保守氧疗、高流量鼻导管给氧疗法、高氧和低氧策略比较以及高压氧治疗研究。首先,保守氧疗降低重症监护病房死亡率的潜力已引起相当关注;然而,需要进一步的临床研究来验证其最佳参数和合适的患者群体。其次,高流量鼻导管给氧疗法已被证明可有效缓解呼吸窘迫并减少插管需求。这种疗法可提供高达60升/分钟的氧流量,有效改善呼吸窘迫并降低插管需求。在高风险拔管患者中,高流量鼻导管给氧疗法与无创通气联合使用可显著降低再插管率,使联合方法成为重症监护病房预防拔管后呼吸衰竭的最佳策略之一。第三,低氧和高氧策略在对患者死亡率、长期结局和临床医生偏好的影响方面存在差异;然而,目前尚无明确证据表明哪种策略更优。临床医生对各种氧合目标的偏好可能会影响未来研究的设计。最后,高压氧治疗被认为是各种危急情况的有效支持治疗方法,在急性重度创伤性脑损伤、脑复苏和心肺复苏中具有重要应用价值。目前,研究人员正在不断探索重症监护病房的最新氧疗方法。几项调查自动氧控制、新型高流量鼻导管给氧疗法和联合氧疗的随机对照临床试验正在进行中。应密切观察这些试验的结果。总体而言,本文为重症监护病房氧疗的科学合理应用提供了系统综述和有价值的参考。未来研究应集中在验证保守氧疗的最佳参数、评估不同患者群体的氧需求、评估氧疗的长期效果以及开发新型氧疗技术和设备上。

相似文献

1
Oxygen therapy in the intensive care unit.重症监护病房中的氧疗。
Med Gas Res. 2025 Dec 1;15(4):478-487. doi: 10.4103/mgr.MEDGASRES-D-24-00143. Epub 2025 Apr 29.
2
High-flow nasal cannulae for respiratory support in adult intensive care patients.用于成人重症监护患者呼吸支持的高流量鼻导管
Cochrane Database Syst Rev. 2017 May 30;5(5):CD010172. doi: 10.1002/14651858.CD010172.pub2.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
High-flow nasal cannulae for respiratory support in adult intensive care patients.高流量鼻导管在成人重症监护患者呼吸支持中的应用。
Cochrane Database Syst Rev. 2021 Mar 4;3(3):CD010172. doi: 10.1002/14651858.CD010172.pub3.
7
Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a rapid review.急性呼吸窘迫综合征机械通气期间重症监护病房的氧疗目标:快速综述
Cochrane Database Syst Rev. 2020 Sep 1;9(9):CD013708. doi: 10.1002/14651858.CD013708.
8
Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial.经鼻高流量湿化氧疗联合无创通气预氧合在 ICU 低氧血症患者中插管:单中心、盲法、随机对照 OPTINIV 试验。
Intensive Care Med. 2016 Dec;42(12):1877-1887. doi: 10.1007/s00134-016-4588-9. Epub 2016 Oct 11.
9
Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial.低危患者拔管后使用高流量鼻导管与常规氧疗对再插管的影响:一项随机临床试验。
JAMA. 2016 Apr 5;315(13):1354-61. doi: 10.1001/jama.2016.2711.
10
[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].[新型冠状病毒肺炎患者呼吸支持的最新应用立场文件 - 德国呼吸学会]
Pneumologie. 2020 Jun;74(6):337-357. doi: 10.1055/a-1157-9976. Epub 2020 Apr 22.

本文引用的文献

1
Less is best for oxygen therapy in adults in the intensive care unit with severe hypoxaemia due to COVID-19.对于因新冠病毒病导致严重低氧血症的重症监护病房成年患者,低流量氧疗是最佳选择。
Intensive Care Med. 2024 Oct;50(10):1685-1687. doi: 10.1007/s00134-024-07554-w. Epub 2024 Sep 12.
2
When to intubate in acute hypoxaemic respiratory failure? Options and opportunities for evidence-informed decision making in the intensive care unit.急性低氧性呼吸衰竭时何时插管?重症监护病房中基于证据的决策选择和机会。
Lancet Respir Med. 2024 Aug;12(8):642-654. doi: 10.1016/S2213-2600(24)00118-8. Epub 2024 May 24.
3
Conservative versus liberal oxygen therapy for intensive care unit patients: meta-analysis of randomized controlled trials.
重症监护病房患者保守性与开放性氧疗:随机对照试验的荟萃分析
Ann Intensive Care. 2024 Apr 26;14(1):68. doi: 10.1186/s13613-024-01300-7.
4
Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.低氧与高氧目标及 COVID-19 患者存活无生命支持天数:HOT-COVID 随机临床试验。
JAMA. 2024 Apr 9;331(14):1185-1194. doi: 10.1001/jama.2024.2934.
5
Individualized Treatment Effects of Oxygen Targets in Mechanically Ventilated Critically Ill Adults.机械通气危重症成人氧目标的个体化治疗效果。
JAMA. 2024 Apr 9;331(14):1195-1204. doi: 10.1001/jama.2024.2933.
6
Protocol and statistical analysis plan for the mega randomised registry trial research program comparing conservative versus liberal oxygenation targets in adults receiving unplanned invasive mechanical ventilation in the ICU (Mega-ROX).比较重症监护病房(ICU)中接受非计划性有创机械通气的成人患者保守与宽松氧合目标的大型随机注册试验研究项目的方案和统计分析计划(Mega-ROX)
Crit Care Resusc. 2023 Oct 19;24(2):137-149. doi: 10.51893/2022.2.OA4. eCollection 2022 Jun 6.
7
Extracorporeal membrane oxygenation for critically ill adults.体外膜肺氧合治疗危重症成人。
Cochrane Database Syst Rev. 2023 Sep 26;9(9):CD010381. doi: 10.1002/14651858.CD010381.pub3.
8
Targeting CXCR1 alleviates hyperoxia-induced lung injury through promoting glutamine metabolism.靶向 CXCR1 通过促进谷氨酰胺代谢缓解高氧诱导的肺损伤。
Cell Rep. 2023 Jul 25;42(7):112745. doi: 10.1016/j.celrep.2023.112745. Epub 2023 Jul 4.
9
Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review.药物治疗降低慢性阻塞性肺疾病死亡风险:一项叙述性综述
Mayo Clin Proc. 2023 Feb;98(2):301-315. doi: 10.1016/j.mayocp.2022.09.007.
10
Practice of oxygen use in anesthesiology - a survey of the European Society of Anaesthesiology and Intensive Care.麻醉学中的氧气使用实践——欧洲麻醉学和重症监护学会的调查。
BMC Anesthesiol. 2022 Nov 14;22(1):350. doi: 10.1186/s12871-022-01884-2.